This action might not be possible to undo. Are you sure you want to continue?
for up to minute schedule visit: www.onemedplace.com WALK UP REGISTRATIONS WELCOME. NO CHARGE TO AUDIT PRESENTATIONS IF SPACE IS AVAILABLE.
Monday 08:15 Jan 7 08:30 08:45 09:00 09:15 09:30 09:45 10:00 10:15 10:30 10:45 11:00 11:10 11:30 12:00
1:30 1:50 2:00 2:20 2:40 3:00 3:20 3:40 4:00 4:20 4:40 5:00 5:20
Tuesday 08:15 Jan 8 08:30 08:45 09:00 09:15 09:30 09:45 10:00 10:15 10:30 10:45 11:00 11:10 11:30 11:50
Rockland Tech Colby Pharma MedicaSafe World Hearing TBD Break MyGenopedia NeoChord TBD Muve Nanomix, Inc. Break Mystic Pharma Chembio Diagnostics* BioJect Medical * Lunch Neoprobe Clarient * SyntheMed, Inc.* Clearant* Cyberkinetics * Break TBD RedPoint* ScyFIX TBD VirtualScopics * TBD Reception
Deep Web Seminar
Venture Term Sheets
Med Tech Venture Outlook
Disruptive Technologies Monetizing Investment
1:30 1:50 2:00 2:20 2:40 3:00
MyGenopedia Deep Web Seminar MedicaSafe Rockland Tech Muve NeoChord Break ScyFIX Venture Term Sheets II Gridlogix Bioject Medical* Symphony Innovent Break State Venture Capital ISTO Austin Texas Haemacure * Endocare * Lunch IVT Diagnostics Panel Accera Safeguard Scientific * CNS Response * Epigenomics * Break Personalized Medicine Panel: Roche Molecular*, Clarient*, Combimatrix, Althea Tech, Natural, Selection, Predict Sciences, Alpha Orthopaedic, Tunitas Therapeutics, CNS Response*. Cryolife* Reception
* Public Companies
COMPANIES PRESENTING AT 2008 FINANCE FORUM
Comments by Medical Technology Investment Digest editors
Accera, Inc. By creating new sources of fuel for the brain, Accera’s ﬁrstin-class treatment for Alzheimer’s Disease aims to attack the underlying causes of the disease rather than its symptoms. Acorn Cardiovascular, Inc. Acorn’s mesh wrap is intended to prevent heart failure or reverse its progression by improving the heart’s structure and function. Colby Pharmaceuticals. Small molecule therapeutics for the treatment of oxidative stress-induced major human diseases. Initial focus on prostate cancer. Combimatrix Semiconductor-based lab-on-a-chip tools for use in identifying and investigating the roles of genes, gene mutations and proteins. Envisioneering Medical Technologies The TargetScan System allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of the prostate. Epigenomics AG Epigenomics can detect cancer and other diseases earlier by monitoring their speciﬁc genetic ﬁngerprint. This early detection could potentially save millions of lives. Gridlogix Total device integration to better manage electronic assets has had big traction in a variety of applications and is now looking to enter the hospital market. ImmunoVaccine Technologies, Inc. (IVT) IVT’s platform technology allows a vaccine to do in one dose what before would take three, vastly improving both the vaccines’ eﬀectiveness and the number of people who can use them. Isto Technologies, Inc. Biologic products to regenerate and restore damaged cartilage and bone. MedicaSafe The abuse of Class IV pharmaceuticals is a health crisis. MedicaSafe is creating solutions for medication adherence that works in the real world. Muve Anti-obesity programs, tools and technologies derived from the Mayo Clinic’s research have been delivering extraordinary results. Mystic Pharmaceuticals, Inc. A precision unit for dose drug delivery for ophthalmic, intranasal applications. This unique drug delivery system could one day prevent a pandemic. Nanomix, Inc. Sensation technology is based on scaleable devices that use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed for a broad range of industrial and medical applications. Natural Selection Natural Selection applies computational intelligence to bioinformatics problems. NeoChord A minimally invasive solution for mitral valve repair. The market for this technology has been estimated at over $2 billion. Rockland Technimed Ltd. Tissue viability imaging contrast agent to determine tissue viability in ischemic conditions. Has capacity to make MRI as powerful as PET Scan. ScyFIX Sight-saving technologies for people suﬀering from degenerative eye diseases. SRS Medical The In-Flow device addresses one of the most signiﬁcant problems in urologic practice: how to provide safe, eﬀective and digniﬁed bladder drainage, particularly for extended periods. Symphony Medical, Inc. Biocompatible polymers and cell therapies to treat patients with heart failure and cardiac arrhythmias through non-ablative means. World Hearing Organization Comprehensive hearing care at onethird current prices via licensed mobile hearing clinics.
Bioject Medical Technologies Inc. (NASDAQ: BJCT) A variety of entirely new ways to inject liquid medication without needles that could become the new standard for care. Chembio Diagnostics, Inc. (CEMI.OB) Rapid tests to aid in the detection of infectious diseases, including HIV and tuberculosis. Clarient Inc. (NASDAQ: CLRT) In-house pathology testing using its proprietary Automated Cellular Imaging System (ACIS) and other cancer services and cutting-edge diagnostics. Clearant, Inc. (CLRA.OB) Powerful pathogen buster for tissue implants and bone allografts. CNS Response, Inc. (CNSO.OB) rEEG technology to assess neurophysiologic abnormalities and guide subsequent psychiatric treatment. Cryolife (NYSE: CRY) Implantable human tissues for use in reconstructive cardiac, vascular, and orthopedic surgeries. Cyberkinetics, Inc. (CYKN.OB) Systems to treat nervous system diseases and disorders. Current focus is brain-machine interface technology. EndoCare (NASDAQ: ENDO) Cryoablation technology for minimally invasive treatment of prostate and renal cancer and tumors in the kidneys, lungs, and liver. Haemacure (TSX:HAE CN) Products to stop bleeding and seal wounds radically faster than any existing therapies, reducing surgery and recovery time. Medicure Inc. (AMEX: MCU) Medicure discovered that a naturally occurring molecule, MC-1, could prevent the strokes and cardiovascular diseases responsible for 40 percent of American deaths. MC-1 is a potentially blockbuster drug with a multi-billion dollar market. Neoprobe Corporation (NEOP.OB) Neoprobe has found a way to use gamma rays to monitor the progress of cancer without an invasive surgery. Redpoint Bio Corporation (RPBC.OB) By enhancing good ﬂavors and blocking bitter ones, Redpoint is making food tastier and healthier while helping the worst-tasting pharmaceuticals go down like a spoonful of sugar. Response Genetics (NASDAQ: RGDX) Vastly improves the speed of drug development through personalized medicine. The company helps pharmaceutical companies ﬁgure out which patients respond to their drugs and which don’t. SyntheMed, Inc. (SYMD.OB) Anti-adhesion products to reduce the formation of adhesions (scar tissue) following a range of surgical procedures.
All about PIPES Private Investments in Public Equities; the role they can and have played in ﬁnancing the emerging company. This session will review recent regulatory changes that may impact their use. Case studies of several PIPE transactions will be discussed. Monday at 9:15 a.m. Negotiating the Venture Term Sheet This session will examine the core principals of the term sheet, preferred stock structuring and strategies for negotiating term sheets that make sense for both companies and investors. Monday at 11:00 and Tuesday at 9:45 a.m. State Sponsored Venture Capital Governments and regional economic development groups are increasingly hungry to attract high wage jobs and are oﬀering considerable incentives to medical technology companies. A look at this approach in Austin, Texas. Tuesday at 11:10 a.m. The Deep Web Experts believe that the treasures of the untapped Web. The internet has played an important role in shaping the future. Yet an estimated three trilion in information still lies within waiting, to be discovered and capitalized upon by talented entrepreneurs and business development executives. Learn how. M&T 8:15 Monetizing your Investment Finding a corporate partner to acquire your company or purchase your technology, whether in license or out license, is an increasingly useful means to monetize a closely held company. Experts discuss the alternatives. Monday 4:00 p.m. Diagnostics Technical advances coupled with macro trends inﬂuencing healthcare - aging of the population, increasing cost of health care, rise in consumerism, and increased cost of drug development - has resulted in growing interest among investors in the diagnostics space. This panel will discuss recent advances in diagnostics and how these will inﬂuence both the economics of health care as well as investment. Tuesday 1:30 p.m. Personalized Medicine Personalized medicine: the tailoring of treatment to a patient’s genetic proﬁle is a term known scientiﬁcally as pharmacogenomics. But what does this term mean to patients? And what does it mean to the industry if we are to move away from the One Size ﬁts all model? An analysis of this emerging science will be led by the thinkers leading its evolution and the companies shaping its future. Tuesday 3:00 p.m.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue reading from where you left off, or restart the preview.